Clinical trial
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects
NCT01602328 is registered in ClinicalTrials.gov with AlloCure Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects
- Lead sponsor
- AlloCure Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 30, 2012
- Completion date
- August 31, 2014
- Enrollment
- 156 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.